Skip to main content
SpringerLink
Log in

Intraocular Lymphoma

  • Chapter
  • First Online:
Ocular Oncology

Part of the book series: Current Practices in Ophthalmology ((CUPROP))

  • 367 Accesses

Abstract

Intraocular lymphoma is one of the great masqueraders in ophthalmology. It is generally divided into vitreoretinal or uveal (iris, ciliary body, and choroid) lymphoma, and each may either be primary or secondary (metastatic). Despite similarities in patient demographic, nomenclature, and treatment, clinical manifestations and systemic prognosis are very different. Vitreoretinal lymphoma is considered a bilateral disease with central nervous system involvement, while uveal lymphoma is more often unilateral and isolated, resulting in a better systemic prognosis and patient survival.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Exp Ophthalmol. 2008;36(6):564–78.

    Article  PubMed  Google Scholar 

  2. Chan CC, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist. 2011;16(11):1589–99.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Cooper EL, Riker JL. Malignant lymphoma of the uveal tract. Am J Ophthalmol. 1951;34(8):1153–8.

    Article  CAS  PubMed  Google Scholar 

  4. Levasseur SD, Wittenberg LA, White VA. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes. JAMA Ophthalmol. 2013;131(1):50–5.

    Article  PubMed  Google Scholar 

  5. Salomao DR, Pulido JS, Johnston PB, Canal-Fontcuberta I, Feldman AL. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma. JAMA Ophthalmol. 2013;131(9):1151–8.

    Article  PubMed  Google Scholar 

  6. Cao X, Shen D, Callanan DG, Mochizuki M, Chan CC. Diagnosis of systemic metastatic retinal lymphoma. Acta Ophthalmol. 2011;89(2):e149–54.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Taki R, Takeda A, Yoshikawa H, Fukuhara T, Arita R, Suehiro Y, et al. Clinical features of systemic metastatic retinal lymphoma in Japanese patients. Ocul Immunol Inflamm. 2017;25(5):654–62.

    Article  PubMed  Google Scholar 

  8. Gass JD, Sever RJ, Grizzard WS, Clarkson JG, Blumenkranz M, Wind CA, et al. Multifocal pigment epithelial detachments by reticulum cell sarcoma. A characteristic funduscopic picture. Retina. 1984;4(3):135–43.

    Article  CAS  PubMed  Google Scholar 

  9. Pang CE, Shields CL, Jumper JM, Yannuzzi LA. Paraneoplastic cloudy vitelliform submaculopathy in primary vitreoretinal lymphoma. Am J Ophthalmol. 2014;158(6):1253–61.e2.

    Article  PubMed  Google Scholar 

  10. Casady M, Faia L, Nazemzadeh M, Nussenblatt R, Chan CC, Sen HN. Fundus autofluorescence patterns in primary intraocular lymphoma. Retina. 2014;34(2):366–72.

    Article  CAS  PubMed  Google Scholar 

  11. Fardeau C, Lee CP, Merle-Beral H, Cassoux N, Bodaghi B, Davi F, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147(5):886–94. 94.e1.

    Article  PubMed  Google Scholar 

  12. Barry RJ, Tasiopoulou A, Murray PI, Patel PJ, Sagoo MS, Denniston AK, et al. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis. Br J Ophthalmol. 2018;102(10):1362–6.

    Article  PubMed  Google Scholar 

  13. Mruthyunjaya P, Jumper JM, McCallum R, Patel DJ, Cox TA, Jaffe GJ. Diagnostic yield of vitrectomy in eyes with suspected posterior segment infection or malignancy. Ophthalmology. 2002;109(6):1123–9.

    Article  PubMed  Google Scholar 

  14. Chan CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc. 2003;101:275–92.

    PubMed  PubMed Central  Google Scholar 

  15. Pulido JS, Salomao DR, Frederick LA, Viswanatha DS. MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma. Retina. 2015;35(4):624–7.

    Article  CAS  PubMed  Google Scholar 

  16. Riemens A, Bromberg J, Touitou V, Sobolewska B, Missotten T, Baarsma S, et al. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study. JAMA Ophthalmol. 2015;133(2):191–7.

    Article  PubMed  Google Scholar 

  17. Chan CC, Sen HN. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma. Discov Med. 2013;15(81):93–100.

    PubMed  PubMed Central  Google Scholar 

  18. Pe’er J, Hochberg FH, Foster CS. Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm. 2009;17(5):299–306.

    Article  PubMed  Google Scholar 

  19. Shields CL, Sioufi K, Mashayekhi A, Shields JA. Intravitreal melphalan for treatment of primary vitreoretinal lymphoma: a new indication for an old drug. JAMA Ophthalmol. 2017;135(7):815–8.

    Article  PubMed  Google Scholar 

  20. Berenbom A, Davila RM, Lin HS, Harbour JW. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye (Lond). 2007;21(9):1198–201.

    Article  CAS  Google Scholar 

  21. Hoffman PM, McKelvie P, Hall AJ, Stawell RJ, Santamaria JD. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye (Lond). 2003;17(4):513–21.

    Article  CAS  Google Scholar 

  22. Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol. 1997;115(9):1152–6.

    Article  CAS  PubMed  Google Scholar 

  23. Smith JR, Rosenbaum JT, Wilson DJ, Doolittle ND, Siegal T, Neuwelt EA, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002;109(9):1709–16.

    Article  PubMed  Google Scholar 

  24. Frenkel S, Hendler K, Siegal T, Shalom E, Pe’er J. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol. 2008;92(3):383–8.

    Article  CAS  PubMed  Google Scholar 

  25. de Smet MD. Management of non Hodgkin’s intraocular lymphoma with intravitreal methotrexate. Bull Soc Belge Ophtalmol. 2001;279:91–5.

    Google Scholar 

  26. Kitzmann AS, Pulido JS, Mohney BG, Baratz KH, Grube T, Marler RJ, et al. Intraocular use of rituximab. Eye (Lond). 2007;21(12):1524–7.

    Article  CAS  Google Scholar 

  27. Mashayekhi A, Shukla SY, Shields JA, Shields CL. Choroidal lymphoma: clinical features and association with systemic lymphoma. Ophthalmology. 2014;121(1):342–51.

    Article  PubMed  Google Scholar 

  28. Aronow ME, Portell CA, Sweetenham JW, Singh AD. Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes. Ophthalmology. 2014;121(1):334–41.

    Article  PubMed  Google Scholar 

  29. Tavallali A, Shields CL, Bianciotto C, Shields JA. Choroidal lymphoma masquerading as anterior ischemic optic neuropathy. Eur J Ophthalmol. 2010;20(5):959–62.

    Article  PubMed  Google Scholar 

  30. Pelegrin L, Adan A, Lopez-Guillermo A, Martinez A, Shields CL. An old disease in an atypical place. Surv Ophthalmol. 2014;59(6):660–3.

    Article  PubMed  Google Scholar 

  31. Velez G, de Smet MD, Whitcup SM, Robinson M, Nussenblatt RB, Chan CC. Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol. 2000;44(6):518–26.

    Article  CAS  PubMed  Google Scholar 

  32. Mashayekhi A, Shields CL, Shields JA. Iris involvement by lymphoma: a review of 13 cases. Clin Exp Ophthalmol. 2013;41(1):19–26.

    Article  PubMed  Google Scholar 

  33. Chang TS, Byrne SF, Gass JD, Hughes JR, Johnson RN, Murray TG. Echographic findings in benign reactive lymphoid hyperplasia of the choroid. Arch Ophthalmol. 1996;114(6):669–75.

    Article  CAS  PubMed  Google Scholar 

  34. Schubert CGAS, Shields CL. The seasick pattern of choroidal lymphoma on enhanced depth imaging optical coherence tomography. Retina. 2014;34(8):1495–512.

    Article  Google Scholar 

  35. Shields CL, Arepalli S, Pellegrini M, Mashayekhi A, Shields JA. Choroidal lymphoma shows calm, rippled, or undulating topography on enhanced depth imaging optical coherence tomography in 14 eyes. Retina. 2014;34(7):1347–53.

    Article  PubMed  Google Scholar 

  36. Grossniklaus HE, Martin DF, Avery R, Shields JA, Shields CL, Kuo IC, et al. Uveal lymphoid infiltration: report of four cases and clinicopathologic review. Ophthalmology. 1998;105(7):1265–73.

    Article  CAS  PubMed  Google Scholar 

  37. Cockerham GC, Hidayat AA, Bijwaard KE, Sheng ZM. Re-evaluation of “reactive lymphoid hyperplasia of the uvea”: an immunohistochemical and molecular analysis of 10 cases. Ophthalmology. 2000;107(1):151–8.

    Article  CAS  PubMed  Google Scholar 

  38. Mashayekhi A, Hasanreisoglu M, Shields CL, Shields JA. External beam radiation for choroidal lymphoma: efficacy and complications. Retina. 2016;36(10):2006–12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Storm Eye Institute, Medical University of South Carolina, Charleston, SC, USA

    George N. Magrath & Emil Anthony T. Say

Authors
  1. George N. Magrath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emil Anthony T. Say
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Louisville, Louisville, KY, USA

    Aparna Ramasubramanian

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Magrath, G.N., Say, E.A.T. (2019). Intraocular Lymphoma. In: Ramasubramanian, A. (eds) Ocular Oncology . Current Practices in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-13-7538-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7538-5_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7537-8

  • Online ISBN: 978-981-13-7538-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation